Yuki Fujiwara Selected Research

Yuki Fujiwara Research Topics

Disease

39	Neoplasms (Cancer) 12/2022 - 09/2009
20	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 10/2010
9	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2011
6	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 09/2009
4	Carcinoma (Carcinomatosis) 01/2016 - 11/2012
3	Lymphatic Metastasis 01/2021 - 05/2017
3	Inflammation (Inflammations) 01/2019 - 09/2016
3	Adenocarcinoma 01/2017 - 09/2015
2	Hypoxia (Hypoxemia) 12/2022 - 01/2021
2	Carcinogenesis 10/2022 - 07/2016
2	Margins of Excision 11/2021 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2021
2	Ascites 01/2018 - 11/2012
2	Pancreatic Fistula (Pancreatic Fistulas) 11/2016 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 04/2012
1	Osteoporosis 04/2024
1	Alzheimer Disease (Alzheimer's Disease) 03/2024
1	Cerebellar Diseases (Cerebellar Syndrome) 08/2023
1	Diabetes Mellitus 07/2023
1	Mediastinitis 07/2023
1	Melanoma (Melanoma, Malignant) 10/2022
1	Hypothyroidism 07/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2022
1	Thrombocytopenia (Thrombopenia) 06/2022
1	Wilms Tumor (Wilm's Tumor) 04/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2022
1	Hematologic Neoplasms (Hematological Malignancy) 02/2022
1	Developmental Disabilities (Developmental Disability) 01/2022
1	Mucormycosis 01/2022
1	Febrile Neutropenia 01/2022
1	Bradycardia 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Hemorrhage 01/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	Malignant Pleural Effusion 01/2021
1	Leukemia 01/2021

Drug/Important Bio-Agent (IBA)

12	nafamostatIBA 01/2018 - 10/2010
6	C-Reactive ProteinIBA 01/2021 - 11/2012
5	AlbuminsIBA 01/2021 - 09/2016
5	Gemcitabine FDA Link 01/2018 - 11/2012
5	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2016 - 10/2010
5	AntigensIBA 12/2015 - 04/2012
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2021 - 12/2010
4	Indicators and Reagents (Reagents)IBA 01/2018 - 09/2015
4	NF-kappa B (NF-kB)IBA 01/2016 - 10/2010
4	CarbohydratesIBA 09/2014 - 04/2012
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2017
3	Messenger RNA (mRNA)IBA 08/2023 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
3	Monoclonal AntibodiesIBA 01/2021 - 12/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2011
3	Interleukin-8 (Interleukin 8)IBA 07/2016 - 09/2011
3	Thromboplastin (Tissue Factor)IBA 04/2016 - 09/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013 - 07/2011
3	Carcinoembryonic AntigenIBA 09/2013 - 04/2012
2	SteroidsIBA 07/2023 - 10/2013
2	Rituximab (Mabthera)FDA Link 06/2022 - 09/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2022 - 01/2021
2	CytokinesIBA 01/2021 - 03/2016
2	Immunoglobulin G (IgG)IBA 09/2020 - 12/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 05/2011
1	Estrogens (Estrogen)FDA Link 04/2024
1	plerixafor FDA Link 12/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2022
1	Immune Checkpoint InhibitorsIBA 10/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2022
1	Chemokine ReceptorsIBA 10/2022
1	ChemokinesIBA 10/2022
1	RGFP966IBA 07/2022
1	Histones (Histone)IBA 07/2022
1	Thyroid HormonesIBA 07/2022
1	obinutuzumabIBA 06/2022
1	Bendamustine Hydrochloride FDA Link 06/2022
1	Chimeric Antigen ReceptorsIBA 02/2022
1	Antifungal AgentsIBA 01/2022
1	liposomal amphotericin B FDA Link 01/2022
1	perfluorooctaneIBA 01/2022
1	posaconazole FDA Link 01/2022
1	Fetal Proteins (Fetoprotein)IBA 11/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	Alkylating AgentsIBA 01/2021
1	Inotuzumab OzogamicinIBA 01/2021
1	blinatumomabIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021

Therapy/Procedure

16	Therapeutics 07/2023 - 09/2009
12	Drug Therapy (Chemotherapy) 12/2022 - 04/2012
9	Pancreaticoduodenectomy 01/2019 - 06/2013
6	Blood Transfusion (Blood Transfusions) 10/2013 - 09/2009
5	Immunotherapy 10/2022 - 03/2016
3	Adjuvant Chemotherapy 12/2022 - 05/2017
3	Hematopoietic Stem Cell Transplantation 04/2022 - 09/2020
3	Neoadjuvant Therapy 10/2020 - 02/2015
3	Combination Drug Therapy (Combination Chemotherapy) 09/2013 - 05/2011
2	Splenectomy 12/2016 - 01/2014
2	Pancreatectomy 12/2016 - 10/2013
2	Subcutaneous Injections 09/2013 - 02/2013
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2022
1	Electrocoagulation (Electrocautery) 01/2021
1	Salvage Therapy 01/2021